• DOI:10.1517/13543784.12.1.39
Corpus ID: 21225474

Cannabinoids for gastrointestinal diseases: potential therapeutic applications

@article{Carlo2003CannabinoidsFG,
  title={Cannabinoids for gastrointestinal diseases: potential therapeutic applications},
  author={G. Carlo and A. Izzo},
  journal={Expert Opinion on Investigational Drugs},
  year={2003},
  volume={12},
  pages={39 - 49}
}

G. Carlo, A. Izzo

Published 2003

Medicine

Expert Opinion on Investigational Drugs

Δ9-Tetrahydrocannabinol (the active ingredient of marijuana), as well as endogenous and synthetic cannabinoids, exert many biological functions by activating two types of cannabinoid receptors, CB1 and CB2 receptors. CB1 receptors have been detected on enteric nerves, and pharmacological effects of their activation include gastroprotection, reduction of gastric and intestinal motility and reduction of intestinal secretion. The digestive tract also contains endogenous cannabinoids (i.e., the… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed